Evidence map›Paper›PMID 28186708›Full record

ArticleStem cells translational medicine2017

Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage Polarization.

Claudia Lo Sicco, Daniele Reverberi, Carolina Balbi, Valentina Ulivi, Elisa Principi, Luisa Pascucci, Pamela Becherini, Maria Carla Bosco, Luigi Varesio, Chiara Franzin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 360 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
360citing papers in PubMed, 4 pooled it
19.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

360 citing papers in PubMed, 4 syntheses or guidelines pooled it, 557 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

300 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Claudia Lo SiccoDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Daniele ReverberiU.O. Molecular Pathology, IRCCS AOU San Martino-IST, National Cancer Research Institute, Genova, Italy.
Carolina BalbiDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Valentina UliviDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Elisa PrincipiDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Luisa PascucciDepartment of Veterinary Medicine, University of Perugia, Perugia, Italy.
Pamela BecheriniMolecular Biology Laboratory, Istituto Giannina Gaslini, Genova, Italy.
Maria Carla BoscoMolecular Biology Laboratory, Istituto Giannina Gaslini, Genova, Italy.
Luigi VaresioMolecular Biology Laboratory, Istituto Giannina Gaslini, Genova, Italy.
Chiara FranzinStem Cells and Regenerative Medicine Lab, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Michela PozzobonStem Cells and Regenerative Medicine Lab, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Ranieri CanceddaDepartment of Experimental Medicine, University of Genova, Genova, Italy.
Roberta TassoU.O. Regenerative Medicine, IRCCS AOU San Martino-IST, National Cancer Research Institute, Genova, Italy.
University of Genoa · ITCittà della Speranza Foundation · ITIstituto Giannina Gaslini · ITIstituto Nazionale di Fisica Nucleare, Sezione di Genova · ITNational Cancer Research Institute · GBOspedale Policlinico San Martino · ITUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal Stem Cells (MSCs) are effective therapeutic agents enhancing the repair of injured tissues mostly through their paracrine activity. Increasing evidences show that besides the secretion of soluble molecules, the release of extracellular vesicles (EVs) represents an alternative mechanism adopted by MSCs. Since macrophages are essential contributors toward the resolution of inflammation, which has emerged as a finely orchestrated process, the aim of the present study was to carry out a detailed characterization of EVs released by human adipose derived-MSCs to investigate their involvement as modulators of MSC anti-inflammatory effects inducing macrophage polarization. The EV-isolation method was based on repeated ultracentrifugations of the medium conditioned by MSC exposed to normoxic or hypoxic conditions (EV

Indexed as

AnimalsAnti-Inflammatory AgentsCell ProliferationCells, CulturedDisease Models, AnimalExtracellular VesiclesFlow CytometryInflammationMacrophagesMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceMice, Inbred C57BLMicroscopy, Electron, TransmissionReal-Time Polymerase Chain ReactionAnti-Inflammatory AgentsCell hypoxiaExtracellular vesiclesInflammationMacrophagesMesenchymal stem cellsRegenerative medicine

Identifiers

PMID28186708
PMCPMC5442783
OpenAlexW2585403859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.